While not a new concept, drug rationing across the United States has become an increasingly critical issue. In another tale about the dangers of high prescription drug costs, researchers published an article inJAMA Network Openexplaininghowdrug prices impact medication adherence, ...
Up to 12% of pharmacy spending may be on high-cost, low-value drugs that can be removed from formularies. Rising prescription drug costs continue to place a financial burden on patients and employers; however, reducing the use of high-cost, low-value drugs on formularies could lower drug ...
Reports on the efforts of states and health insurers to deal with prescription costs in the U.S. Use of generic versions of drugs; Increase in drug costs which have grown at double-digit rates; Efforts to strike a balance between affordable prices for drugs and profits at pharmaceutical ...
The high cost of prescription drugs threatens healthcare budgets, and limits funding available for other areas in which public investment is needed. In countries without universal healthcare, the high cost of prescription drugs poses an additional threat: unaffordable out-of-pocket costs for individual...
patients are pushed into nonadherence which means a patient skips medicines or does not fill the prescription. ‘Right to life’ is a fundamental right of human beings, so the high drug costs problem is a vital ethical issue that needs to be solved by the governments, the pharmaceutical indust...
“However, expensive life-saving drugs– some of which are close to six figures for treatment– threaten to derail the progress made in expanding health coverage. To contain rising healthcare costs, we must contain skyrocketing prescription drug costs.” ...
Both put a sharp focus on the issues of fair marketing and pricing practices for prescription drugs. And, by ignoring the potential of physicians to serve as agents of change, both fail to provide concrete steps to alleviate the problem of prescription drug costs in America.H. Jeffrey Lawrence...
These clawbacks are contributing to the high costs of prescription drugs. Keller Rohrback L.L.P. has filed and is litigating suits against OptumRx, CIGNA Corp. and UnitedHealth for their clawback schemes. Learn more about the cases here. Please contact attorney Gretchen Obrist to learn more ...
An economist at The University of Texas at Austin will brief members of Congress on how insurers are using high out-of-pocket prescription drug costs to deter certain chronically ill patients from joining their plans in the individual markets. ...
High Costs Lead Millions of Americans to Shop Abroad for Rx Drugs FRIDAY, June 26, 2020 (HealthDay News) -- More than 2 million Americans buy prescription drugs from other countries as a way around rising prices in the United States, a new study finds. ...